Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: Preliminary studies

References

• McIntyre JA, Wagenknecht DR, Faulk WP. Redox-reactive antibodies: Detection and physiological relevance. Autoimmun Rev 2006; 5: 76–83
   PubMed Web of Science ®Google Scholar
• Cabiedes J, Cabal AR, Alarcon-Segovia D. Hidden antiphospholipid antibodies in normal human sera circulate as immune complexes whose antigen can be removed by heat, acid, hypermolar buffers, or phospholipase treatments. Eur J Immunol 1998; 28: 2108–2114
   PubMed Web of Science ®Google Scholar
• Lorber M, George J, Shoenfeld Y. Hidden autoantibodies. Autoantibodies, J Peter, Y Shoenfeld. Elsevier Science BV, Amsterdam 1996; 357–363
   Google Scholar
• Tomer Y, Shoenfeld Y. The significance of natural autoantibodies. Immunol Invest 1988; 17: 389–424
   PubMed Web of Science ®Google Scholar
• McIntyre JA, Wagenknecht DR, Faulk WP. Autoantibodies unmasked by redox reactions. J Autoimmun 2005; 24: 311–317
   PubMed Web of Science ®Google Scholar
• McIntyre JA. The appearance and disappearance of antiphospholipid antibodies subsequent to oxidation–reduction reactions. Thromb Res 2004; 114: 579–587
   PubMed Web of Science ®Google Scholar
• McIntyre JA, Wagenknecht DR, Faulk WP. Redox-reactive autoantibodies. Autoantibodies2nd ed., Y Shoenfeld, PL Meroni, ME Gershwin. Elsevier, Amsterdam 2007; 47–53
   Google Scholar
• Katzav A, Litvinjuk Y, Pick CG, Blank M, Shoenfeld Y, Sirota P, Chapman J. Genetic and immunological factors interact in a mouse model of CNS antiphospholipid syndrome. Behav Brain Res 2006; 169: 289–293
   Google Scholar
• Shoenfeld Y, Nahum A, Korczyn AD, Dano M, Rabinowitz R, Beilin O, Pick CG, Leider-Trejo L, Kalashnikova L, Blank M, Chapman J. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 2003; 12: 436–442
   Web of Science ®Google Scholar
• Ziporen L, Shoenfeld Y, Levy Y, Korczyn AD. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. J Clin Invest 1997; 100: 613–615
   PubMed Web of Science ®Google Scholar
• Ischiropoulos H, Beckman JS. Oxidative stress and nitration in neurodegeneration: Cause, effect, or association?. J Clin Invest 2003; 111: 163–169
   PubMed Web of Science ®Google Scholar
• Smith MA, Richey Harris PL, Sayre LM, Sayre LM, Beckman JS, Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997; 17: 2653–2657
   PubMed Web of Science ®Google Scholar
• Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E, Isobe C. Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neurosci Lett 1999; 269: 52–54
   PubMed Web of Science ®Google Scholar
• Cuajungco MP, Faget KY, Xudong H, Tanzi RE, Bush AI. Metal chelation as a potential therapy for Alzheimer's disease. Ann NY Acad Sci 2000; 920: 292–304
   PubMed Web of Science ®Google Scholar
• Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann NY Acad Sci 2004; 1012: 153–163
   PubMed Web of Science ®Google Scholar
• McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939–944
   PubMed Web of Science ®Google Scholar
• Hamilton RL. Lewy bodies in Alzheimer's disease: A neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 2000; 10: 378–384
   PubMed Web of Science ®Google Scholar
• Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, vanBelle G, Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479–486
   PubMed Web of Science ®Google Scholar
• Anon. The National Institute on Aging and Regan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease: Consensus Recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997; 18(4 Supplement 1)S1–S2
   Google Scholar
• Wagenknecht DR, Becker DG, LeFor WM, McIntyre JA. Antiphospholipid antibodies are a risk factor for early renal allograft failure. Transplantation 1999; 68: 241–246
   PubMed Web of Science ®Google Scholar
• Shavit E, Chapman J. Antiphospholipid antibodies activate ERK and depolarize brain synaptosomes. Immunobiology 2005; 209(S1)40
   Google Scholar
• Sokol DK, Wagenknecht DR, McIntyre JA. Testing for antiphospholipid antibody (aPL) specificities in retrospective “normal” cerebral spinal fluid (CSF). Clin Dev Immunol 2004; 11: 7–12
   Google Scholar
• Ehrlich P. Das sauerstufbudurfnis des organismus. Eine Farbenanalytische Studie. Hirschwald, Berlin 1885
   Google Scholar
• Silverstein AM. Autoimmunity versus horror autotoxicus: The struggle for recognition. Nat Immunol 2001; 2: 279–281
   PubMed Web of Science ®Google Scholar
• Gallo P, Sivieri S, Ferrarini AM, Giometto B, Ruffitti A, Ritter E, Chizzolini C, Tavolato B. Cerebrovascular and neurological disorders associated with antiphospholipid antibodies in CSF and serum. J Neurol Sci 1994; 122(1)97–101
   Google Scholar
• Knopf PM, Harling-Berg CJ, Cserr HF, Basu D, Sirulnick EJ, Nolan SC, Park JT, Keir G, Thompson EJ, Hickey WF. Antigen-dependent intrathecal antibody synthesis in the normal rat brain: Tissue entry and local retention of antigen-specific B cells. J Immunol 1998; 161: 692–701
   PubMed Web of Science ®Google Scholar
• Lai N-S, Lan J-L. Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations. Lupus 2000; 9: 353–357
   PubMed Web of Science ®Google Scholar
• Leonardi A, Gandolfo C, Caponnetto L, Arata L, Vecchia R. The integrity of the blood–brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid. J Neurol Sci 1985; 67: 253–261
   Google Scholar
• Lawson LJ, Perry VH, Dri P, Gorden S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990; 39: 151–170
   PubMed Web of Science ®Google Scholar
• Morgan BP, Gasque P. Expression of complement in the brain: Role in health and disease. Immunol Today 1996; 17: 445–493
   Google Scholar
• D'Andrea MR. Add Alzheimer's disease to the list of autoimmune diseases. Med Hypotheses 2005; 64: 458–463
   PubMed Web of Science ®Google Scholar
• D'Andrea MR. Evidence linking neuronal cell death to autoimmunity in Alzheimer's disease. Brain Res. 2003; 982: 9–30
   Google Scholar
• Dimitrov JD, Ivanovska ND, Lacroix-Desmazes S, Doltchinkova VR, Kaveri SV, Vassilev TL. Ferrous ions and reactive oxygen species increase antigen-binding and anti-inflammatory activities of immunoglobulin G. J Biol Chem. 2006; 281: 439–446
   PubMed Web of Science ®Google Scholar
• Bozic B, Cucnik S, Kveder T, Rozman B. Changes in avidity and specificity if IgG during electro-oxidation. Relevance of binding of antibodies to B2-GPI. Autoimmun Rev 2006; 6: 28–32
   PubMed Web of Science ®Google Scholar
• Adams JP, Sweatt JD. Molecular psychology: Roles for the ERK MAP Kinase cascade in memory. Ann Rev Pharmacol Toxicol. 2002; 42: 135–163
   PubMed Web of Science ®Google Scholar
• Cheung EC, Slack RS. Emerging role for ERK as a key regulator of neuronal apoptosis. Science STKE. 2004; 251: 1–4
   Google Scholar
• Colucci-D'Amato L, Perrone-Capano C, diPorzio U. Chronic activation of ERK and neurodegenerative diseases. BioEssays 2003; 25: 1085–1095
   Google Scholar
• Hindley A, Kolch W. Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of RAF kinases. J Cell Sci. 2002; 115: 1575–1581
   PubMed Web of Science ®Google Scholar
• Selcher JC, Weeber EJ, Christia J, Nekrasova T, Landreth GE, Sweatt JD. A role for ERK MAP Kinase in physiologic temporal integration in hippocampal area CA1. Learn Mem 2006; 10: 26–39, Cold Spring Harbor Laboratory Press
   Google Scholar
• Winder DG, Martin KC, Muzzio IA, Rohrer D, Chruscinski A, Kobilka B, Kandel ER. ERK plays a regulatory role in induction of LTP by theta frequency stimulation and its modulation by B-adrenergic receptors. Neuron 1999; 24: 715–726
   Google Scholar
• Zhao M, Adams JP, Dudek SM. Pattern-dependent role of NMDA receptors in action potential generation: Consequences on extracellular signal-regulated kinase activation. J Neurosci. 2005; 25: 7032–7039
   Google Scholar
• Chapman J, Cohen-Armon M, Shoenfeld Y, Korczyn AD. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 1999; 8: 127–133
   PubMed Web of Science ®Google Scholar
• DeKosky ST, Marek K. Looking backward to move forward: Early detection of neurodegenerative disorders. Science 2003; 302: 830–834
   PubMed Web of Science ®Google Scholar